1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Floor Backes: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer Lenvatinib Mesylate, Paclitaxel, Pharmacological Study - Fallopian Tube Carcinoma, Recurrent Ovarian Cancer | Phase 1 | Completed | Floor Backes | 26 | 2016-05-27 | 2022-09-19 |
Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1)
Paclitaxel (1) · Taxes (1) · lenvatinib (1)
United States (1)